Combination drug therapy

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Medical Microbiology / Quality of life / Public Health / HIV / Humans / Human immunodeficiency virus / Combination drug therapy / Mechanism of action / Fixed dose combination / Human immunodeficiency virus / Combination drug therapy / Mechanism of action / Fixed dose combination

Tratamiento antirretroviral de inicio en pacientes infectados por el virus de la inmunodeficiencia humana en España: decisiones con relación a características inmunovirológicas específicas (estudio PERFIL-es)

Medical Microbiology / HIV / Spain / Humans / Highly Active Antiretroviral Therapy / Retrospective Studies / Combination drug therapy / Drug Utilization / Viral Load / Retrospective Studies / Combination drug therapy / Drug Utilization / Viral Load

Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2007)

Evidence Based Medicine / Medical Microbiology / Comorbidity / Spain / Therapeutic drug monitoring / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Medical Microbiology / Quality of life / Public Health / HIV / Humans / Human immunodeficiency virus / Combination drug therapy / Mechanism of action / Fixed dose combination / Human immunodeficiency virus / Combination drug therapy / Mechanism of action / Fixed dose combination

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Costes directos sanitarios en pacientes con diabetes mellitus tipo 2 a los seis meses de inicio del tratamiento con insulina en España: estudio INSTIGATE

Treatment Outcome / Comorbidity / Spain / Prospective studies / Humans / Blood Glucose / Insulin / Diabetes mellitus / Europe / Hospitalization / Female / Male / Aged / Middle Aged / Health Expenditures / Oral Hypoglycemic Agents / Drug Costs / Combination drug therapy / Type 2 Diabetes Mellitus / Prospective Study / Blood Glucose / Insulin / Diabetes mellitus / Europe / Hospitalization / Female / Male / Aged / Middle Aged / Health Expenditures / Oral Hypoglycemic Agents / Drug Costs / Combination drug therapy / Type 2 Diabetes Mellitus / Prospective Study

Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema

Treatment Outcome / Optical coherence tomography / Ophthalmic / Visual acuity / Prospective studies / Humans / Diabetic Retinopathy / Female / Male / Retina / Follow-up studies / Monoclonal Antibodies / Aged / Middle Aged / Optometry and Ophthalmology / Triamcinolone Acetonide / Adult / Combination drug therapy / Type 2 Diabetes Mellitus / Glucocorticoids / Macular edema / Injections / Humans / Diabetic Retinopathy / Female / Male / Retina / Follow-up studies / Monoclonal Antibodies / Aged / Middle Aged / Optometry and Ophthalmology / Triamcinolone Acetonide / Adult / Combination drug therapy / Type 2 Diabetes Mellitus / Glucocorticoids / Macular edema / Injections

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Antimalarial Exposure Delays Plasmodium falciparum Intra-Erythrocytic Cycle and Drives Drug Transporter Genes Expression

Cell Cycle / Gene expression / Multidisciplinary / Drug Resistance / Membrane transport proteins / PLoS one / Plasmodium falciparum / Antimalarials / Combination drug therapy / Protozoan Proteins / Erythrocytes / Non linear regression / Mefloquine / Gene Expression Regulation / PLoS one / Plasmodium falciparum / Antimalarials / Combination drug therapy / Protozoan Proteins / Erythrocytes / Non linear regression / Mefloquine / Gene Expression Regulation

Unusual Kaposi\'s sarcoma in a renal transplant recipient

Kidney transplantation / Humans / Male / Follow-up studies / Clinical Sciences / Adult / Combination drug therapy / X ray Computed Tomography / Chronic Kidney Failure / Antineoplastic Agents / Skin Neoplasms / Adult / Combination drug therapy / X ray Computed Tomography / Chronic Kidney Failure / Antineoplastic Agents / Skin Neoplasms

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Medical Microbiology / Quality of life / Public Health / HIV / Humans / Human immunodeficiency virus / Combination drug therapy / Mechanism of action / Fixed dose combination / Human immunodeficiency virus / Combination drug therapy / Mechanism of action / Fixed dose combination

Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2007)

Evidence Based Medicine / Medical Microbiology / Comorbidity / Spain / Therapeutic drug monitoring / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load

Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004)

Evidence Based Medicine / Medical Microbiology / Comorbidity / Spain / Therapeutic drug monitoring / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load

Usar rifampicina más pirazinamida en profilaxis antituberculosa no incrementa el riesgo de hepatotoxicidad grave en pacientes infectados por virus de la inmunodeficiencia humana: metaanálisis de ensayos clínicos aleatorizados y controlados

Medical Microbiology / Risk / Tuberculosis / Humans / Antibiotic Prophylaxis / Hiv Infection / Human immunodeficiency virus / Enfermedades / Combination drug therapy / Isoniazid / Drug Induced Liver Injury / Pyrazinamide / Latent tuberculosis infection / Hiv Infection / Human immunodeficiency virus / Enfermedades / Combination drug therapy / Isoniazid / Drug Induced Liver Injury / Pyrazinamide / Latent tuberculosis infection

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
Copyright © 2017 DATOSPDF Inc.